K. Benwell

发表

Characterization of iodoacetate-mediated neurotoxicity in vitro using primary cultures of rat cerebellar granule cells.

R. Porter, C. Malcolm, K. Benwell, 2000, Free radical biology & medicine.

Pyrrolo(iso)quinoline derivatives as 5-HT(2C) receptor agonists.

G. Kennett, C. Dourish, D. Adams, 2006, Bioorganic & medicinal chemistry letters.

Discovery and functional evaluation of diverse novel human CB(1) receptor ligands.

Nicolas Foloppe, N. Foloppe, G. Kennett, 2009, Bioorganic & medicinal chemistry letters.

The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake

G. Kennett, Z. Thornton-Jones, P. G. Clifton, 2006, Pharmacology Biochemistry and Behavior.

Targeting DYRK1A/B kinases to modulate p21‐cyclin D1‐p27 signalling and induce anti‐tumour activity in a model of human glioblastoma

A. Massey, D. Walmsley, A. Kotschy, 2021, Journal of cellular and molecular medicine.

Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureas.

Melanie H. Wong, S. Lightowler, G. Kennett, 2009, Bioorganic & medicinal chemistry letters.

Comparative effects of continuous infusion of mCPP, Ro 60‐0175 and d‐fenfluramine on food intake, water intake, body weight and locomotor activity in rats

G. Kennett, C. Dourish, G A Kennett, 2000, British journal of pharmacology.

Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activity.

Melanie H. Wong, S. Lightowler, G. Kennett, 2012, Bioorganic & medicinal chemistry letters.

3,5-Disubstituted-4-hydroxyphenyls Linked to 3-Hydroxy-2-methyl- 4(1H)-pyridinone: Potent Inhibitors of Lipid Peroxidation and Cell Toxicity

A. Palmer, C. Malcolm, K. Benwell, 2000 .

Recombinant soluble human CD69 dimer produced in Escherichia coli: reevaluation of saccharide binding.

G. Dougan, A. M. Lawson, G. Frankel, 1999, Biochemical and biophysical research communications.

Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors

G. Kennett, Guy Kennett, Anil Misra, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson’s disease

C. Dourish, S. Weiss, J. Lerpiniere, 2003, Neurology.

Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives.

A. Lawrence, R. Gillespie, S. Ward, 2008, Bioorganic & medicinal chemistry letters.

Functional characterization of agonists at recombinant human 5‐HT2A, 5‐HT2B and 5‐HT2C receptors in CHO‐K1 cells

R. Porter, M J Sheardown, R H Porter, 1999, British journal of pharmacology.

Indoline derivatives as 5-HT(2C) receptor agonists.

G. Kennett, C. Dourish, D. Adams, 2004, Bioorganic & medicinal chemistry letters.

Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors.

N. Foloppe, J. Murray, R. Hubbard, 2021, Journal of medicinal chemistry.

Discovery and optimization of potent and selective functional antagonists of the human adenosine A2B receptor.

A. Knight, Melanie H. Wong, S. Lightowler, 2009, Bioorganic & medicinal chemistry letters.